Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Champions Oncology, Inc. (CSBR)

7.48   0.1 (1.36%) 05-16 00:56
Open: 7.37 Pre. Close: 7.38
High: 7.53 Low: 7.37
Volume: 1,967 Market Cap: 101(M)
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.54 - 7.57 7.57 - 7.6
Low: 7.29 - 7.33 7.33 - 7.36
Close: 7.43 - 7.48 7.48 - 7.53

Technical analysis

as of: 2022-05-13 4:37:18 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 9.01     One year: 9.64
Support: Support1: 6.84    Support2: 5.69
Resistance: Resistance1: 7.71    Resistance2: 8.26
Pivot: 7.51
Moving Average: MA(5): 7.31     MA(20): 7.64
MA(100): 7.95     MA(250): 9.02
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 47.9     %D(3): 37.9
RSI: RSI(14): 43.5
52-week: High: 11.25  Low: 6.84
Average Vol(K): 3-Month: 6 (K)  10-Days: 5 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CSBR ] has closed above bottom band by 46.3%. Bollinger Bands are 12.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 08 May 2022
Bhandup STP bid 54% below estimate, BMC to go to South Korea to verify tech - Times of India

Tue, 03 May 2022
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo - Yahoo Finance

Fri, 29 Apr 2022
Community: LSU announces Tiger 12 Senior Class of 2022 - The Advocate

Tue, 15 Feb 2022
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors - Yahoo Finance

Thu, 20 Jan 2022
Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates - BioSpace

Fri, 03 Dec 2021
What kind of year did national markets close in terms of competition, how did GVH see 2021? - BBJ - Budapest Business Journal

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 14 (M)
% Held by Insiders 5.48e+006 (%)
% Held by Institutions 29.2 (%)
Shares Short 67 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS 0.01
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 203
Profit Margin (%) 0.8
Operating Margin (%) 0.9
Return on Assets (ttm) 0.9
Return on Equity (ttm) 5.2
Qtrly Rev. Growth 16.5
Gross Profit (p.s.) 1.9396e+007
Sales Per Share 4.39703e+007
EBITDA (p.s.) 1.67327e+006
Qtrly Earnings Growth 30
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 374
PEG Ratio 8.9
Price to Book value 0.03
Price to Sales 0
Price to Cash Flow 12.59

Stock Dividends

Dividend 0
Forward Dividend 66940
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.